Medtronic plc Earnings Per Share Disclosure
| Fiscal Year | |||||||||||||||||
| (in millions, except per share data) | 2025 | 2024 | 2023 | ||||||||||||||
| Numerator: | |||||||||||||||||
| Net income attributable to ordinary shareholders | $ | 4,662 | $ | 3,676 | $ | 3,758 | |||||||||||
| Denominator: | |||||||||||||||||
| Basic – weighted average shares outstanding | 1,285.6 | 1,327.7 | 1,329.8 | ||||||||||||||
| Effect of dilutive securities: | |||||||||||||||||
| Employee stock options | 0.5 | 0.7 | 1.5 | ||||||||||||||
| Employee restricted stock units | 2.2 | 1.4 | 1.0 | ||||||||||||||
| Employee performance share units | 1.5 | 0.4 | 0.5 | ||||||||||||||
| Diluted – weighted average shares outstanding | 1,289.9 | 1,330.2 | 1,332.8 | ||||||||||||||
| Basic earnings per share | $ | 3.63 | $ | 2.77 | $ | 2.83 | |||||||||||
| Diluted earnings per share | $ | 3.61 | $ | 2.76 | $ | 2.82 | |||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Jun 20, 2025 | Showing above |
| 2024 | Jun 20, 2024 | |
| 2023 | Jun 22, 2023 | |
| 2022 | Jun 23, 2022 | |
| 2021 | Jun 25, 2021 | |
| 2020 | Jun 19, 2020 | |
| 2019 | Jun 21, 2019 | |
| 2018 | Jun 22, 2018 | |
| 2017 | Jun 27, 2017 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.